North of England Evidence Based Development Project: Guideline for Angiotensin Converting Enzyme Inhibitors in Primary Care Management of Adults with Symptomatic Heart Failure

Overview

Journal BMJ

Specialty General Medicine

Date 1998 Jun 6

PMID 9563995

Citations 22

Authors

M Eccles

N Freemantle

J Mason

Affiliations

Soon will be listed here.

Citing Articles

Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands.

Bootsma J, Warle-van Herwaarden M, Verbeek A, Fussenich P, De Smet P, Rikkert M Drug Saf. 2011; 34(7):605-14.

PMID: 21663336 DOI: 10.2165/11587250-000000000-00000.

Role of the angiotensin II receptor blocker valsartan in heart failure.

Webb R, de Gasparo M Exp Clin Cardiol. 2010; 6(4):215-21.

PMID: 20428262 PMC: 2859003.

Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.

Ward P, Noyce P, St Leger A Ther Clin Risk Manag. 2008; 1(1):61-8.

PMID: 18360545 PMC: 1661602. DOI: 10.2147/tcrm.1.1.61.53599.

Best practice in primary care pathology: review 6.

Smellie W, Forth J, Coleman J, Irvine W, Dore P, Handley G J Clin Pathol. 2006; 60(3):225-34.

PMID: 16822875 PMC: 1860559. DOI: 10.1136/jcp.2006.040014.

Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract.

Leslie S, McKee S, Imray E, Denvir M Postgrad Med J. 2005; 81(955):321-6.

PMID: 15879046 PMC: 1743274. DOI: 10.1136/pgmj.2004.022947.

References

. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group. J Am Coll Cardiol. 1983; 2(4):755-63. DOI: 10.1016/s0735-1097(83)80316-7. View

. Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. Eur Heart J. 1995; 16(6):741-51. View

Nicholls M, Ikram H, Espiner E, Webster M, Fitzpatrick M . Enalapril in heart failure. Br J Clin Pharmacol. 1984; 18 Suppl 2:163S-167S. PMC: 1463468. DOI: 10.1111/j.1365-2125.1984.tb02594.x. View

Cleland J, Dargie H, Ball S, Gillen G, Hodsman G, Morton J . Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985; 54(3):305-12. PMC: 481900. DOI: 10.1136/hrt.54.3.305. View

Magnani B, Magelli C . Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial. Postgrad Med J. 1986; 62 Suppl 1:153-8. View

. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316(23):1429-35. DOI: 10.1056/NEJM198706043162301. View

Bussmann W, Storger H, Hadler D, Reifart N, Fassbinder W, Jungmann E . Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study. J Cardiovasc Pharmacol. 1987; 9 Suppl 2:S50-60. DOI: 10.1097/00005344-198700002-00012. View

. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. JAMA. 1988; 259(4):539-44. View

ONeill C, Bowes S, Sullens C, Royston J, Hunt W, Denham M . Evaluation of the safety of enalapril in the treatment of heart failure in the very old. Eur J Clin Pharmacol. 1988; 35(2):143-50. DOI: 10.1007/BF00609243. View

10.

Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M, Just H . Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation. 1989; 79(3):491-502. DOI: 10.1161/01.cir.79.3.491. View

11.

Frank G . The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure. Cardiology. 1989; 76 Suppl 2:56-67. DOI: 10.1159/000174560. View

12.

Riegger G . The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure. J Cardiovasc Pharmacol. 1990; 15 Suppl 2:S41-6. DOI: 10.1097/00005344-199000152-00008. View

13.

Remes J, Miettinen H, Reunanen A, Pyorala K . Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991; 12(3):315-21. DOI: 10.1093/oxfordjournals.eurheartj.a059896. View

14.

Yusuf S, Pitt B, Davis C, Hood W, Cohn J . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991; 325(5):293-302. DOI: 10.1056/NEJM199108013250501. View

15.

Dickstein K, Barvik S, Aarsland T . Effect of long-term enalapril therapy on cardiopulmonary exercise performance in men with mild heart failure and previous myocardial infarction. J Am Coll Cardiol. 1991; 18(2):596-602. DOI: 10.1016/0735-1097(91)90619-k. View

16.

Barabino A, Galbariggi G, Pizzorni C, Lotti G . Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients. Cardiology. 1991; 78(3):243-56. DOI: 10.1159/000174791. View

17.

Colfer H, Ribner H, Gradman A, Hughes C, Kapoor A, Laidlaw J . Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group. Am J Cardiol. 1992; 70(3):354-8. DOI: 10.1016/0002-9149(92)90618-9. View

18.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

19.

Yusuf S, Pitt B, Davis C, Hood Jr W, Cohn J . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327(10):685-91. DOI: 10.1056/NEJM199209033271003. View

20.

Kleber F, Niemoller L, Doering W . Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J. 1992; 67(4):289-96. PMC: 1024835. DOI: 10.1136/hrt.67.4.289. View